Vincristine and dactinomycin in infantile myofibromatosis with a review of treatment options

Meaghann S. Weaver, Fariba Navid, Alison Huppmann, Holly Meany, Anne Angiolillo

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Although solitary presentations of infantile myofibromatosis tend toward spontaneous regression, multicentric forms fare worse. Previous case reports have depicted observation, surgical resection, and systemic therapies as treatment options. This paper reports well-tolerated, successful outcomes in a series of patients with high-risk infantile myofibromatosis in need of life-sustaining interventions treated with a combination of vincristine and dactinomycin. The clinical presentation, pathology, and radiographic findings are described.

Original languageEnglish (US)
Pages (from-to)237-241
Number of pages5
JournalJournal of Pediatric Hematology/Oncology
Volume37
Issue number3
DOIs
StatePublished - Apr 7 2015

Fingerprint

Dactinomycin
Vincristine
Clinical Pathology
Observation
Therapeutics
Congenital Generalized Fibromatosis

Keywords

  • Infantile myofibromatosis
  • dactinomycin
  • vincristine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Vincristine and dactinomycin in infantile myofibromatosis with a review of treatment options. / Weaver, Meaghann S.; Navid, Fariba; Huppmann, Alison; Meany, Holly; Angiolillo, Anne.

In: Journal of Pediatric Hematology/Oncology, Vol. 37, No. 3, 07.04.2015, p. 237-241.

Research output: Contribution to journalReview article

Weaver, Meaghann S. ; Navid, Fariba ; Huppmann, Alison ; Meany, Holly ; Angiolillo, Anne. / Vincristine and dactinomycin in infantile myofibromatosis with a review of treatment options. In: Journal of Pediatric Hematology/Oncology. 2015 ; Vol. 37, No. 3. pp. 237-241.
@article{6a100e90da714436bf472d1fc41fad71,
title = "Vincristine and dactinomycin in infantile myofibromatosis with a review of treatment options",
abstract = "Although solitary presentations of infantile myofibromatosis tend toward spontaneous regression, multicentric forms fare worse. Previous case reports have depicted observation, surgical resection, and systemic therapies as treatment options. This paper reports well-tolerated, successful outcomes in a series of patients with high-risk infantile myofibromatosis in need of life-sustaining interventions treated with a combination of vincristine and dactinomycin. The clinical presentation, pathology, and radiographic findings are described.",
keywords = "Infantile myofibromatosis, dactinomycin, vincristine",
author = "Weaver, {Meaghann S.} and Fariba Navid and Alison Huppmann and Holly Meany and Anne Angiolillo",
year = "2015",
month = "4",
day = "7",
doi = "10.1097/MPH.0000000000000286",
language = "English (US)",
volume = "37",
pages = "237--241",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Vincristine and dactinomycin in infantile myofibromatosis with a review of treatment options

AU - Weaver, Meaghann S.

AU - Navid, Fariba

AU - Huppmann, Alison

AU - Meany, Holly

AU - Angiolillo, Anne

PY - 2015/4/7

Y1 - 2015/4/7

N2 - Although solitary presentations of infantile myofibromatosis tend toward spontaneous regression, multicentric forms fare worse. Previous case reports have depicted observation, surgical resection, and systemic therapies as treatment options. This paper reports well-tolerated, successful outcomes in a series of patients with high-risk infantile myofibromatosis in need of life-sustaining interventions treated with a combination of vincristine and dactinomycin. The clinical presentation, pathology, and radiographic findings are described.

AB - Although solitary presentations of infantile myofibromatosis tend toward spontaneous regression, multicentric forms fare worse. Previous case reports have depicted observation, surgical resection, and systemic therapies as treatment options. This paper reports well-tolerated, successful outcomes in a series of patients with high-risk infantile myofibromatosis in need of life-sustaining interventions treated with a combination of vincristine and dactinomycin. The clinical presentation, pathology, and radiographic findings are described.

KW - Infantile myofibromatosis

KW - dactinomycin

KW - vincristine

UR - http://www.scopus.com/inward/record.url?scp=84926418397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926418397&partnerID=8YFLogxK

U2 - 10.1097/MPH.0000000000000286

DO - 10.1097/MPH.0000000000000286

M3 - Review article

C2 - 25389917

AN - SCOPUS:84926418397

VL - 37

SP - 237

EP - 241

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 3

ER -